| Colleen Elizabeth Vehafric, | |
|
1345 Birch Ave, Cottage Grove, OR 97424-1416 | |
| (541) 942-3939 | |
| Not Available |
| Full Name | Colleen Elizabeth Vehafric |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 1345 Birch Ave, Cottage Grove, Oregon |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124594379 | NPI | - | NPPES |
| 500650666 | Medicaid | OR |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Colleen Elizabeth Vehafric, 1345 Birch Ave, Cottage Grove, OR 97424-1416 Ph: (541) 942-3939 | Colleen Elizabeth Vehafric, 1345 Birch Ave, Cottage Grove, OR 97424-1416 Ph: (541) 942-3939 |
News Archive
A new Phase I clinical trial conducted at Cedars-Sinai Medical Center's Maxine Dunitz Neurosurgical Institute in Los Angeles shows that two innovative treatment approaches may safely be combined to treat patients with highly aggressive, malignant brain tumors called gliomas. The results suggest that combining the two therapies might boost their effectiveness and supports the pursuit of additional studies on this approach to treating these tumors.
Investigators report that torcetrapib, a drug that substantially raises high-density lipoprotein cholesterol or HDL (the "good" cholesterol), did not slow the progression of plaque buildup in the coronary arteries as measured using an ultrasound probe (IVUS).
HHS Secretary Kathleen Sebelius announced today that the U.S. Department of Health and Human Services (HHS) is joining with the Ad Council to launch a new nationwide public service advertising (PSA) campaign called "Together We Can All Fight the Flu."
Receptos, Inc., a privately held biopharmaceutical company, announced the closing of a two-tranche $25 million Series A financing. The company is focused on identifying and developing best- and first-in-class GPCR therapeutic candidates through information-driven drug discovery, including GPCR structure. Investors include ARCH Venture Partners, Flagship Ventures, Lilly Ventures and Venrock.
A Cedars-Sinai research scientist has been awarded two national grants totaling more than $2.5 million, including a prestigious Research Project Grant from the National Institutes of Health to study potential treatments for Alzheimer's disease.
› Verified 7 days ago
Therese N Mastin, M.A., QMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 1345 Birch Ave, Cottage Grove, OR 97424 Phone: 541-942-3939 Fax: 541-942-9310 | |
Sonja Therese Towner, Counselor Medicare: Not Enrolled in Medicare Practice Location: 37 N 6th St, Cottage Grove, OR 97424 Phone: 541-942-3939 | |
Brianna Elaine Dunn, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1345 Birch Ave, Cottage Grove, OR 97424 Phone: 541-942-3939 | |
Tessa Hart, MED, QMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 1345 Birch Ave, Cottage Grove, OR 97424 Phone: 541-942-3939 | |
Susan Grzesiak, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1345 Birch Ave, Cottage Grove, OR 97424 Phone: 541-942-3939 Fax: 541-942-9310 | |
Robert H Lee, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1345 Birch Ave, Cottage Grove, OR 97424 Phone: 541-942-3939 Fax: 541-942-9310 | |
Mrs. Sarah Marie Baker, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1245 Birch Ave, Cottage Grove, OR 97424 Phone: 541-942-3939 |